TABLE1.
DNA nanoparticles in chemotherapy.
| Chemotherapeutic Drugs | DNA Nanostructures | Modification | Effect | Ref |
|---|---|---|---|---|
| Doxorubicin | DNA tetrahedron | Folate receptor | Apoptosis promoting | Zhang et al. (2017b) |
| KLA peptide | Drug delivery and apoptosis promoting | Yan et al. (2020) | ||
| AS1411 + MUC1 aptamer | Breast cancer cell imaging and drug delivery | Liu et al. (2018a) | ||
| Affibody | Selectivity and inhibition of breast cancer cells | Zhang et al. (2017c) | ||
| DNA octahedron | Folate | Selective targeting | Raniolo et al. (2018) | |
| DNA icosahedron | MUC1 aptamer | Efficient and specific internalization for killing epithelial cancer cells | Chang et al. (2011) | |
| DNA NFs | Sgc8 | Nuclease resistance and binding of different functional moieties | Lv et al. (2015) | |
| DNA triangle and tube | - | Increased doxorubicin cellular internalization and elevated susceptibility to drug-resistant adenocarcinoma cells | Bertrand et al. (2014) | |
| RCA-based nanostructures | Imotif sequence, Sgc8 | pH-Responsive Drug Delivery | Zhao et al. (2018) | |
| Daunorubicin | DNA nanorod | - | Circumvent drug-resistance mechanisms in a leukemia model | Halley et al. (2016) |
| Platinum | DNA tetrahedron | - | Targeted platinum drug delivery | Wu et al. (2019) |
| DNA icosahedron | Telomerase-Responsive | Precise delivery of platinum nanodrugs to cisplatin-resistant cancer | Ma et al. (2018) |